Published in Heart Vessels on May 28, 2016
Aliskiren suppresses atrial electrical and structural remodeling in a canine model of atrial fibrillation. Heart Vessels (2016) 0.76
Ibutilide protects against cardiomyocytes injury via inhibiting endoplasmic reticulum and mitochondrial stress pathways. Heart Vessels (2016) 0.75
Significance of right atrial tension for the development of complications in patients after atriopulmonary connection Fontan procedure: potential indicator for Fontan conversion. Heart Vessels (2017) 0.75
p53 in health and disease. Nat Rev Mol Cell Biol (2007) 11.33
Increased vulnerability to atrial fibrillation in transgenic mice with selective atrial fibrosis caused by overexpression of TGF-beta1. Circ Res (2004) 3.30
Oxidative stress-mediated cardiac cell death is a major determinant of ventricular dysfunction and failure in dog dilated cardiomyopathy. Circ Res (2001) 2.89
Effects of angiotensin II type 1 receptor antagonist on electrical and structural remodeling in atrial fibrillation. J Am Coll Cardiol (2003) 2.52
Effects of angiotensin-converting enzyme inhibition on the development of the atrial fibrillation substrate in dogs with ventricular tachypacing-induced congestive heart failure. Circulation (2001) 2.27
Differences in atrial versus ventricular remodeling in dogs with ventricular tachypacing-induced congestive heart failure. Cardiovasc Res (2004) 2.06
Atrial fibrillation pathophysiology: implications for management. Circulation (2011) 2.01
Atrial but not ventricular fibrosis in mice expressing a mutant transforming growth factor-beta(1) transgene in the heart. Circ Res (2000) 1.82
Angiotensin II antagonist prevents electrical remodeling in atrial fibrillation. Circulation (2000) 1.74
Role of angiotensin system and effects of its inhibition in atrial fibrillation: clinical and experimental evidence. Eur Heart J (2005) 1.71
Angiotensin II receptor blockade does not improve left ventricular function and remodeling in subacute mitral regurgitation in the dog. J Am Coll Cardiol (2002) 1.65
Differential behaviors of atrial versus ventricular fibroblasts: a potential role for platelet-derived growth factor in atrial-ventricular remodeling differences. Circulation (2008) 1.61
Atrial cardiomyocyte tachycardia alters cardiac fibroblast function: a novel consideration in atrial remodeling. Cardiovasc Res (2007) 1.22
Loss of Mdm4 results in p53-dependent dilated cardiomyopathy. Circulation (2007) 1.21
Animal models for atrial fibrillation: clinical insights and scientific opportunities. Europace (2009) 1.20
The tumor suppressor p53 abrogates Smad-dependent collagen gene induction in mesenchymal cells. J Biol Chem (2004) 1.05
Tranilast prevents atrial remodeling and development of atrial fibrillation in a canine model of atrial tachycardia and left ventricular dysfunction. J Am Coll Cardiol (2012) 0.92
Roles of the left atrial roof and pulmonary veins in the anatomic substrate for persistent atrial fibrillation and ablation in a canine model. J Am Coll Cardiol (2010) 0.91
Metastasis-associated protein, S100A4 mediates cardiac fibrosis potentially through the modulation of p53 in cardiac fibroblasts. J Mol Cell Cardiol (2013) 0.90
Inhibition of p53 after acute myocardial infarction: reduction of apoptosis is counteracted by disturbed scar formation and cardiac rupture. J Mol Cell Cardiol (2010) 0.90
Enalapril prevents perpetuation of atrial fibrillation by suppressing atrial fibrosis and over-expression of connexin43 in a canine model of atrial pacing-induced left ventricular dysfunction. J Cardiovasc Pharmacol (2004) 0.89
Senescent cardiac fibroblast is critical for cardiac fibrosis after myocardial infarction. PLoS One (2013) 0.89
Atrial fibrillation compendium: historical context and detailed translational perspective on an important clinical problem. Circ Res (2014) 0.87
Cardiac protective effects of irbesartan via the PPAR-gamma signaling pathway in angiotensin-converting enzyme 2-deficient mice. J Transl Med (2013) 0.80
Prevention of recurrences in patients with lone atrial fibrillation. The dose-dependent effect of angiotensin II receptor blockers. J Renin Angiotensin Aldosterone Syst (2004) 0.79
Catheter ablation of atrial fibrillation in patients with severely impaired left ventricular systolic function. Heart Vessels (2015) 0.78
Effects of irbesartan on gene expression revealed by transcriptome analysis of left atrial tissue in a porcine model of acute rapid pacing in vivo. Int J Cardiol (2013) 0.78
Pharmacokinetic and pharmacodynamic interaction between irbesartan and hydrochlorothiazide in renal hypertensive dogs. J Cardiovasc Pharmacol (2005) 0.77
Beneficial effects of losartan for prevention of paroxysmal atrial fibrillation in patients with sick sinus syndrome: analysis with memory function of pacemaker. Heart Vessels (2015) 0.76
Time-Dependent Changes in QT Dynamics after Initiation and Termination of Paroxysmal Atrial Fibrillation. Pacing Clin Electrophysiol (2015) 0.77
Impact of Blood Pressure Control on Thromboembolism and Major Hemorrhage in Patients With Nonvalvular Atrial Fibrillation: A Subanalysis of the J-RHYTHM Registry. J Am Heart Assoc (2016) 0.75
Left atrial wall thickness is associated with the low-voltage area in patients with paroxysmal atrial fibrillation. J Interv Card Electrophysiol (2019) 0.75
Paced QRS fragmentation is associated with spontaneous ventricular fibrillation in patients with Brugada syndrome. Heart Rhythm (2016) 0.75
Impact of creatinine clearance on outcomes in patients with non-valvular atrial fibrillation: a subanalysis of the J-RHYTHM Registry. Eur Heart J Qual Care Clin Outcomes (2017) 0.75
Impact of right ventricular distensibility on congestive heart failure with preserved left ventricular ejection fraction in the elderly. Heart Vessels (2017) 0.75
Accessory pathway location affects brain natriuretic peptide level in patients with Wolff-Parkinson-White syndrome. J Interv Card Electrophysiol (2016) 0.75
Differentiation of Slow-Slow Form of AVNRT from AVRT through a Posteroseptal Accessory Pathway by Retrograde P-Wave Amplitude. Pacing Clin Electrophysiol (2016) 0.75
Cycle Length Alternation during Atrioventricular Reentrant Tachycardia: What Is the Mechanism? Pacing Clin Electrophysiol (2017) 0.75
Secondary stroke prevention with apixaban in nonvalvular atrial fibrillation: A subgroup analysis of the STANDARD study. J Stroke Cerebrovasc Dis (2020) 0.75